Beam Therapeutics Inc. financial data

Symbol
BEAM on Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
Location
26 Landsdowne Street, Cambridge, MA
State of incorporation
DE
Fiscal year end
December 31
Latest financial report
10-K - Q4 2024 - Feb 25, 2025

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 558 % +7.7%
Debt-to-equity 48.7 % -22.8%
Return On Equity -45.8 % -188%
Return On Assets -30.8 % -216%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 83.7M shares +1.67%
Common Stock, Shares, Outstanding 83.6M shares +2.45%
Entity Public Float 1.91B USD -9.48%
Common Stock, Value, Issued 836K USD +2.45%
Weighted Average Number of Shares Outstanding, Basic 82.3M shares +6.69%
Weighted Average Number of Shares Outstanding, Diluted 82.3M shares +6.69%

Income Statement

Label TTM Value / Value Unit Change %
Revenue from Contract with Customer, Excluding Assessed Tax 63.5M USD -83.2%
Research and Development Expense 368M USD -16%
General and Administrative Expense 112M USD -4.53%
Operating Income (Loss) -416M USD -135%
Nonoperating Income (Expense) 38.9M USD -14.3%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest -96.7M USD -0.6%
Income Tax Expense (Benefit) 1.41M USD -58.8%
Net Income (Loss) Attributable to Parent -377M USD -184%
Earnings Per Share, Basic -4.58 USD/shares -166%
Earnings Per Share, Diluted -4.58 USD/shares -166%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 282M USD -35.3%
Marketable Securities, Current 696M USD -17.8%
Cash, Cash Equivalents, and Short-term Investments 851M USD -29.1%
Assets, Current 878M USD -27.5%
Property, Plant and Equipment, Net 111M USD -10.8%
Operating Lease, Right-of-Use Asset 105M USD -7.07%
Other Assets, Noncurrent 1.25M USD -41.6%
Assets 1.1B USD -24.4%
Accounts Payable, Current 3.87M USD +139%
Employee-related Liabilities, Current 21.6M USD -0.93%
Contract with Customer, Liability, Current 109M USD +58.4%
Liabilities, Current 182M USD -11.4%
Contract with Customer, Liability, Noncurrent 33.2M USD -69.8%
Operating Lease, Liability, Noncurrent 148M USD -7.48%
Other Liabilities, Noncurrent 504K USD +69.1%
Liabilities 370M USD -22.6%
Accumulated Other Comprehensive Income (Loss), Net of Tax 679K USD +12.4%
Retained Earnings (Accumulated Deficit) -1.57B USD -31.7%
Stockholders' Equity Attributable to Parent 734M USD -25.3%
Liabilities and Equity 1.1B USD -24.4%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -99.7M USD +9.17%
Net Cash Provided by (Used in) Financing Activities 2.9M USD -97.1%
Net Cash Provided by (Used in) Investing Activities -53.5M USD -310%
Common Stock, Shares Authorized 250M shares 0%
Common Stock, Shares, Issued 83.6M shares +2.45%
Common Stock, Par or Stated Value Per Share 0.01 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect -150M USD -1170%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 290M USD -34.8%
Interest Paid, Excluding Capitalized Interest, Operating Activities 14K USD -77.4%
Deferred Tax Assets, Valuation Allowance 438M USD +33.1%
Deferred Tax Assets, Gross 469M USD +28%
Operating Lease, Liability 161M USD -6.52%
Depreciation 21.9M USD +9.56%
Payments to Acquire Property, Plant, and Equipment 2.44M USD -59.5%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent -377M USD -191%
Lessee, Operating Lease, Liability, to be Paid 228M USD -9.38%
Property, Plant and Equipment, Gross 184M USD +4.78%
Operating Lease, Liability, Current 13.5M USD +5.41%
Lessee, Operating Lease, Liability, to be Paid, Year Two 22.5M USD -11%
Lessee, Operating Lease, Liability, to be Paid, Year One 24.4M USD -2.5%
Operating Lease, Weighted Average Discount Rate, Percent 0.07 pure 0%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 66.3M USD -15.6%
Lessee, Operating Lease, Liability, to be Paid, Year Three 23.2M USD +2.8%
Deferred Tax Assets, Operating Loss Carryforwards 49M USD +1137%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 25M shares 0%
Lessee, Operating Lease, Liability, to be Paid, Year Four 23.4M USD +0.94%
Additional Paid in Capital 2.3B USD +5.94%
Preferred Stock, Shares Outstanding 0 shares
Depreciation, Depletion and Amortization 5.43M USD +16.9%
Share-based Payment Arrangement, Expense 121M USD +22.3%
Preferred Stock, Par or Stated Value Per Share 0.01 USD/shares 0%